The percentage of CD206+ macrophages was decreased in the released patients with CML-CP (9.03 ± 2.01)%, CML-AP (17.24 ± 3.27)%, and CML-BP groups (34.04 ± 5.06)%, respectively. This evidence concerns the gene MRC1 and alkaline phosphatase measurement.